SAN DIEGO, March 15, 2011 /PRNewswire/ — OncoSec Medical, Inc.
(OTC Bulletin Board:
ONCSD) announced today that Mr. Punit Dhillon, President and
CEO, will present a company overview on Wednesday, March 16 at 2:00
pm PT at the ROTH 23rd Annual Growth Stock Conference being held at
the Ritz-Carlton, Laguna Niguel, CA.
(Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO)
Conference details: http://www.roth.com/main/Page.aspx?PageID=7236
About OncoSec Medical Inc.
OncoSec (OTC BB: ONCS.D), based in San Diego, California,
designs, develops and commercializes innovative and proprietary
medical approaches to treat solid tumor cancers with unmet medical
needs or where currently approved therapies are inadequate based on
their efficacy level or side effect profile. The company’s
therapies are based on the use of electroporation delivery in
combination with an approved chemotherapeutic drug or a cytokine
agent to treat solid tumors. More information is available at www.oncosec.com.
This press release contains forward looking statements within
the meaning of the U.S. Private Securities Litigation Reform Act of
1995. Any statements in this release that are not historical facts
may be considered such “forward looking statements.” Forward
looking statements are based on management’s current preliminary
expectations and are subject to risks and uncertainties which may
cause our results to differ materially and adversely from the
statements contained herein. Some of the potential risks and
uncertainties that could cause actual results to differ from those
predicted include our ability to raise additional funding,
uncertainties inherent in pre-clinical studies and clinical
trial
‘/>”/>
SOURCE
